PDL BioPharma (PDLI)

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2017 Results - Earnings Call Transcript
Aug. 4, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2017 Results - Earnings Call Transcript
May 3, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2016 Results - Earnings Call Transcript
Nov. 3, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2016 Results - Earnings Call Transcript
Aug. 7, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2016 Results - Earnings Call Transcript
May 4, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2015 Results - Earnings Call Webcast
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2015 Results - Earnings Call Transcript
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2015 Results - Earnings Call Transcript
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2015 Results - Earnings Call Webcast
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q2 2015 Results - Earnings Call Webcast
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2015 Results - Earnings call Transcript
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2014 Results - Earnings Call Webcast
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2014 Results -- Earnings Call Transcript
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2014 Results - Earnings Call Transcript
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2014 Results - Earnings Call Webcast
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript
Aug. 19, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2014 Results - Earnings Call Transcript
May 12, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Discusses Q4 2013 Results (Webcast)
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Piper Jaffray 2013 Healthcare Conference (Transcript)
Dec. 3, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Jeffries 2013 Global Healthcare Conference (Transcript)
Nov. 21, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Credit Suisse Healthcare Conference Transcript
Nov. 13, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma Q3 2013 Earnings Conference Call Transcript
Nov. 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 6, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Management Discusses Q2 2013 Results (Webcast)
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2013 Earnings Conference Call Transcript
Aug. 8, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at Goldman Sachs Healthcare Conference Transcript
June 11, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
June 11, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Jefferies Global Healthcare Conference Transcript
June 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript
May 9, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2013 Earnings Conference Call Transcript
May 9, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at Cowen Health Care Conference Transcript
March 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma Q4 2012 Earnings Conference Call Transcript
March 1, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript
March 1, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at RBC Capital Markets\' Healthcare Conference Transcript
Feb. 27, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at JPMorgan Global Healthcare Conference Transcript
Jan. 10, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at 31st Annual JPMorgan Healthcare Conference (Transcript)
Jan. 10, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Lazard Capital Markets Healthcare Conference - Transcript
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2012 Earnings Conference Call Transcript
Nov. 5, 2012 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 5, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's Management Presents at UBS Global Life Sciences Conference (Transcript)
Sept. 19, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at UBS Global Life Sciences Conference Transcript
Sept. 19, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma at Think Equity Growth Conference Transcript
Sept. 13, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma at Rodman & Renshaw Global Investment Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 4, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2012 Earnings Conference Call Transcript
Aug. 2, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma President Presents at Goldman Sachs Annual Global Healthcare Conference (Transcript)
June 7, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q1 2012 Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Morningstar

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb. 23, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
Jan. 12, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q3 2011 Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Morningstar

PDL Biopharma's CEO Discusses Q2 2011 Results - Earnings Call Transcript
July 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL Biopharma's CEO Discusses Q1 2011 Results - Earnings Call Transcript
April 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2010 Results - Earnings Call Transcript
Feb. 28, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q3 2010 Results – Earnings Call Transcript
Nov. 10, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2010 Earnings Call Transcript
July 28, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2010 Earnings Call Transcript
April 29, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2009 Earnings Call Transcript
March 2, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2009 Earnings Call Transcript
Oct. 28, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2009 Earnings Call Transcript
July 30, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2009 Earnings Call Transcript
May 7, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2008 Earnings Call Transcript
March 2, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q3 2008 Earnings Call Transcript
Nov. 6, 2008 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2007 Earnings Call Transcript
Aug. 1, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2007 Earnings Call Transcript
May 2, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2006 Earnings Call Transcript
Feb. 21, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2006 Earnings Call Transcript
Nov. 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q1 2006 Earnings Conference Call Transcript (PDLI)
May 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2005 Earnings Conference Call Transcript (PDLI)
Feb. 28, 2006 | Price: Free! | Source: Seeking Alpha

Recent filings

Completion of Acquisition or Disposition of - Sept. 21, 2017

PDL BioPharma's President just picked up 240,200 shares - Sept. 13, 2017

PDL BioPharma's President just declared 0 ownership of the company. - Sept. 13, 2017

Securities to be offered to employees in employee benefit plans - Sept. 12, 2017

PDL: Cook Williams Communications, Inc - Sept. 11, 2017

Current report, items 7.01 and 9.01 - Sept. 11, 2017

Securities to be offered to employees in employee benefit plans - Sept. 7, 2017

PDL: Cook Williams Communications, Inc - Aug. 3, 2017

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Aug. 3, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Termination of a Material Definitive - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Submission of Matters to a Vote of Security - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Current report, items 7.01 and 9.01 - June 7, 2017

PDL: Cook Williams Communications, Inc - June 5, 2017

And Pdl Biopharma Complete Strategic Financial RESTRUCTURING OF LENSAR - May 11, 2017

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - May 3, 2017

PDL BioPharma releases salary data. CEO sees compensation rise 7% - April 28, 2017

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 28, 2017

PDL: Cook Williams Communications, Inc - April 6, 2017

Vice President of PDL BioPharma just picked up 25,000 shares - March 27, 2017

On March - March 21, 2017

On March - March 14, 2017

Departure of Directors or Certain - March 10, 2017

On March - March 8, 2017

PDL BioPharma's VP Business Development just picked up 199,019 shares - March 7, 2017

PDL BioPharma's Controller and CAO just picked up 98,039 shares - March 7, 2017

VP of PDL BioPharma just picked up 214,372 shares - March 7, 2017

President of PDL BioPharma just picked up 588,235 shares - March 7, 2017

Vice President of PDL BioPharma just picked up 212,669 shares - March 7, 2017

PDL BioPharma Just Filed Its Annual Report: 3. Net Income per Sh... - March 1, 2017

PDL: Cook Williams Communications, Inc - March 1, 2017

PDL: Cook Williams Communications, Inc - March 1, 2017

On February 21 and - Feb. 21, 2017

Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 14, 2017

The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 10, 2017

First Trust Portfolios L.P. just provided an update on share ownership of PDL BioPharma - Jan. 31, 2017

BlackRock, Inc. just provided an update on share ownership of PDL BioPharma - Jan. 25, 2017

Beginning on January - Jan. 9, 2017

Entry into a Material Definitive - Dec. 20, 2016

Departure of Directors or Certain - Dec. 16, 2016

VP of PDL BioPharma just disposed of 1,935 shares - Dec. 15, 2016

PDL BioPharma's Controller and CAO just disposed of 663 shares - Dec. 15, 2016

Vice President of PDL BioPharma just disposed of 1,919 shares - Dec. 15, 2016

PDL BioPharma's VP Business Development just disposed of 1,844 shares - Dec. 15, 2016

President of PDL BioPharma just disposed of 5,168 shares - Dec. 15, 2016

Entry into a Material Definitive - Nov. 28, 2016

PDL: Cook Williams Communications, Inc - Nov. 22, 2016

Entry into a Material Definitive - Nov. 22, 2016

Filing [Trust Indenture Act] - Nov. 18, 2016

PDL BioPharma just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 18, 2016

Regulation FD - Nov. 17, 2016

Filing under Securities Act Rules 163/433 of free writing prospectuses - Nov. 17, 2016

PDL: Cook Williams Communications, Inc - Nov. 17, 2016

Filing under Securities Act Rules 163/433 of free writing prospectuses - Nov. 16, 2016

PDL BioPharma just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 15, 2016

PDL: Cook Williams Communications, Inc - Nov. 15, 2016

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Nov. 3, 2016

PDL: Cook Williams Communications, Inc - Nov. 3, 2016

Beginning on October - Oct. 18, 2016

PDL: The Audited Special Purpose Financial Statements Exhibit - Sept. 13, 2016

Confidential treatment order - Sept. 8, 2016

PDL: Cook Williams Communications, Inc - Aug. 29, 2016

Vice President of PDL BioPharma just picked up 10,000 shares - Aug. 10, 2016

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Aug. 4, 2016

PDL: Cook Williams Communications, Inc - Aug. 4, 2016

PDL: Cook Williams Communications, Inc - Aug. 4, 2016

Financial Statements and - Aug. 3, 2016

PDL: Cook Williams Communications, Inc - Aug. 1, 2016

PDL: Cook Williams Communications, Inc - July 6, 2016

Regulation FD - July 6, 2016

PDL BioPharma Just Received a Notice of Effectiveness - June 28, 2016

Delaying amendment - June 14, 2016

PDL: Cook Williams Communications, Inc - June 13, 2016

Registration statement under Securities Act of 1933 - June 10, 2016

Beginning on June - June 7, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

Submission of Matters to a Vote of Security - June 3, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

PDL BioPharma director just picked up 71,023 shares - June 3, 2016

Regulation FD - June 2, 2016

Entry into a Material Definitive - May 24, 2016

Entry into a Material Definitive - May 11, 2016

PDL: Cook Williams Communications, Inc - May 4, 2016

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 21, 2016

PDL BioPharma releases salary data. CEO sees compensation fall -5% - April 21, 2016

PDL: Cook Williams Communications, Inc - March 31, 2016

On March - March 7, 2016

PDL BioPharma Just Filed Its Annual Report: 3. Net Income per Sh... - Feb. 23, 2016

PDL: Cook Williams Communications, Inc - Feb. 22, 2016

The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 11, 2016

Schroder Investment Management North America Ltd just issued a filing suggesting it has sold all of its PDL BioPharma - Feb. 10, 2016

On February - Feb. 8, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. ASCEND CAPITAL, LLC 43,840,000 0.3 June 30, 2017
2. UBS GLOBAL ASSET MANAGEMENT AMERICAS INC 37,337,872 N/A June 30, 2017
3. Whitebox Advisors LLC 25,181,000 1.0 June 30, 2017
4. WOLVERINE ASSET MANAGEMENT LLC 16,729,100 0.1 June 30, 2017
5. Pinnacle Summer Investments, Inc. 16,672,546 0.1 Dec. 31, 2015
6. Citadel Advisors LLC 15,280,069 N/A June 30, 2017
7. OAKTREE CAPITAL MANAGEMENT LP 13,000,000 0.2 June 30, 2017
8. VANGUARD GROUP INC 12,870,461 N/A June 30, 2017
9. ZAZOVE ASSOCIATES LLC 11,960,000 0.6 June 30, 2017
10. Radcliffe Capital Management, L.P. 11,598,000 1.7 June 30, 2017
11. First Trust Portfolios L.P. 10,709,055 N/A Oct. 31, 2015
12. RENAISSANCE TECHNOLOGIES LLC 10,704,400 N/A June 30, 2017
13. LINDEN ADVISORS LP 9,000,000 0.3 June 30, 2017
14. Pine River Capital Management L.P. 8,109,000 0.3 June 30, 2017
15. Context Capital Management, LLC 8,075,000 4.4 June 30, 2017
16. DIMENSIONAL FUND ADVISORS LP 7,428,030 N/A June 30, 2017
17. DEUTSCHE BANK AG\ 6,831,608 N/A June 30, 2017
18. BlackRock Fund Advisors 6,401,415 N/A Sept. 30, 2016
19. BlackRock Institutional Trust Company, N.A. 5,819,729 N/A Dec. 31, 2016
20. Bank of New York Mellon Corp 5,678,265 N/A Dec. 31, 2016
21. Bank of New York Mellon Corp 5,057,872 N/A June 30, 2017
22. State Street Corp 5,042,207 N/A June 30, 2017
23. CNH PARTNERS LLC 5,000,000 N/A June 30, 2017
24. ACADIAN ASSET MANAGEMENT LLC 4,822,932 0.1 June 30, 2017
25. Man Investments (CH) AG 4,500,000 2.6 June 30, 2017
26. AQR CAPITAL MANAGEMENT LLC 4,360,986 N/A June 30, 2017
27. MACKENZIE FINANCIAL CORP 3,650,544 N/A June 30, 2017
28. MORGAN STANLEY 3,492,068 N/A Dec. 31, 2016
29. Catalyst Capital Advisors LLC 2,987,000 0.1 June 30, 2017
30. SCHWAB CHARLES INVESTMENT MANAGEMENT INC 2,877,105 N/A June 30, 2017

PDL BioPharma (PDLI)

140
 


Feedback